Reports
Asia Pacific COVID-19 Diagnostics Market: By Test Type: PCR Test, Antigen Test, Antibody Test, Others; By Product; By Sample Type; By Business Model: Point-of-Care (PoC) Testing, Non-Point-of-Care (PoC) Testing; By End Use: Hospitals, Diagnostic Centres and Clinics, Laboratories; By Country (2020-2026); Competitive Landscape, 2024-2032
Asia Pacific COVID-19 Diagnostics Market Outlook
The Asia Pacific COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in India and China, which have performed around 234 million and 160 million tests, respectively, for COVID-19 as of March 2021.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Number of COVID-19 Cases is Driving the COVID-19 Diagnostics Industry Growth
The demand for COVID-19 diagnostics is growing due to a rise in the number of COVID positive cases, with China being initially the hardest affected country due to the country’s relatively higher population density. India emerged as the most adversely impacted country in the Asia Pacific owing to rapid cases of coronavirus in the country. Many Asia Pacific countries are scrambling to expand their scanning and research capabilities. Many large biotech and pharmaceutical firms have developed their own COVID-19 diagnostics, and many more are now saving, studying, and designing better and more sophisticated COVID-19 diagnostics. This, in particular, is supposed to generate attractive business growth prospects in the coming years. Government policies that benefit detection kit producers are enabling them to expand production volume, which is expected to boost the demand outlook.
COVID-19 Diagnostics: Market Segmentation
COVID-19 diagnostics are standardized equipment used for the detection and diagnosis of Covid-19. These are manufactured by approved pharmaceutical manufacturers under strict government procedures.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By test type, the market is divided into:
- PCR Test
- Antigen Test
- Antibody Test
- Others
The market is categorised in terms of product into:
- RT-PCR Assay Kits
- Immunoassay Test Strips
- Others
The market is divided on the basis of sample type into:
- Nasopharyngeal Swab
- Oropharyngeal (OP) Swab
- Nasal Swab
- Blood Test
- Others
On the basis of business model, the industry is bifurcated into:
- Point-of-Care (PoC) Testing
- Non-Point-of-Care (PoC) Testing
In terms of end use, the market is segmented into:
- Hospitals
- Diagnostic Centres and Clinics
- Laboratories
- Others
The EMR report looks into the regional markets of the product like China, India, Japan, ASEAN, Australia, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Demand for Nasopharyngeal Swabs Aiding the Growth of COVID-19 Diagnostics Market
The most revenue is expected to come from the nasopharyngeal swabs market. SARS-CoV-2 susceptibility, detection rate, and viral load have all been shown to be substantially higher in nasopharyngeal swabs than in other swab types. As a result, this swab type is most often used when checking for COVID-19 and determining SARS-CoV-2 load, resulting in the segment's highest revenue share. This segment is expected to rise at a lucrative pace during the forecast period, owing to increased demand and availability of nasopharyngeal swabs. Furthermore, nasopharyngeal swabs are used in the bulk of molecular diagnostic tests for infection diagnosis.
Key Industry Players in the Asia Pacific COVID-19 Diagnostics Market
The report gives a detailed analysis of the following key players in the Asia Pacific COVID-19 diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Guangzhou Wondfo Biotech Co., Ltd.
- SolGent Co., Ltd.
- Biolidics Limited
- PT Bio Farma (Persero)
- Beijing Jinwofu Bioengineering Technology Co.,Ltd.
- Mylab Discovery Solutions Pvt. Ltd.
- Ellume Limited
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Test Type, Product, Sample Type, Business Model, End Use, Region |
| Breakup by Test Type | PCR Test, Antigen Test, Antibody Test, Others |
| Breakup by Product | RT-PCR Assay Kits, Immunoassay Test Strips, Others |
| Breakup by Sample Type | Nasopharyngeal Swab, Oropharyngeal (OP) Swab, Nasal Swab, Blood Test, Others |
| Breakup by Business Model | Point-of-Care (PoC) Testing, Non-Point-of-Care (PoC) Testing |
| Breakup by End Use | Hospitals, Diagnostic Centres and Clinics, Laboratories, Others |
| Breakup by Region | China, India, Japan, ASEAN, Australia, Others |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Guangzhou Wondfo Biotech Co., Ltd., SolGent Co., Ltd., Biolidics Limited, PT Bio Farma (Persero), Beijing Jinwofu Bioengineering Technology Co.,Ltd., Mylab Discovery Solutions Pvt. Ltd., Ellume Limited, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Asia Pacific
7 Industry Opportunities and Challenges
8 Asia Pacific COVID-19 Overview
8.1 Number of COVID-19 Cases in Asia Pacific
8.2 Asia Pacific COVID-19 Cases by Country
8.2.1 China
8.2.2 Japan
8.2.3 India
8.2.4 ASEAN
8.2.5 Australia
8.2.6 Others
9 Asia Pacific COVID-19 Diagnostics Market Analysis
9.1 Key Industry Highlights
9.2 Asia Pacific COVID-19 Diagnostics Market (2020-2026)
9.3 Asia Pacific COVID-19 Diagnostics Market by Test Type (2020-2026)
9.3.1 PCR Test
9.3.2 Antigen Test
9.3.3 Antibody Test
9.3.4 Others
9.4 Asia Pacific COVID-19 Diagnostics Market by Product (2020-2026)
9.4.1 RT-PCR Assay Kits
9.4.2 Immunoassay Test Strips
9.4.3 Others
9.5 Asia Pacific COVID-19 Diagnostics Market by Sample Type (2020-2026)
9.5.1 Nasopharyngeal Swab
9.5.2 Oropharyngeal (OP) Swab
9.5.3 Nasal Swab
9.5.4 Blood Test
9.5.5 Others
9.6 Asia Pacific COVID-19 Diagnostics Market by Business Model (2020-2026)
9.6.1 Point-of-Care (PoC) Testing
9.6.2 Non-Point-of-Care (PoC) Testing
9.7 Asia Pacific COVID-19 Diagnostics Market by End Use (2020-2026)
9.7.1 Hospitals
9.7.2 Diagnostic Centres and Clinics
9.7.3 Laboratories
9.7.4 Others
9.8 Asia Pacific COVID-19 Diagnostics Market by Region (2020-2026)
9.8.1 China
9.8.2 India
9.8.3 Japan
9.8.4 ASEAN
9.8.5 Australia
9.8.6 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Guangzhou Wondfo Biotech Co., Ltd.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 SolGent Co., Ltd.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Biolidics Limited
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 PT Bio Farma (Persero)
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Beijing Jinwofu Bioengineering Technology Co.,Ltd.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Mylab Discovery Solutions Pvt. Ltd.
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Ellume Limited
11.2.7.1 Company Overview
11.2.7.2 Product Portfolio
11.2.7.3 Demographic Reach and Achievements
11.2.7.4 Certifications
11.2.8 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Asia Pacific COVID-19 Cases by Country
2. Asia Pacific COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
3. Asia Pacific COVID-19 Diagnostics Market: Breakup by Test Type (USD Billion)
4. Asia Pacific COVID-19 Diagnostics Market: Breakup by Product (USD Billion)
5. Asia Pacific COVID-19 Diagnostics Market: Breakup by Sample Type (USD Billion)
6. Asia Pacific COVID-19 Diagnostics Market: Breakup by Business Model (USD Billion)
7. Asia Pacific COVID-19 Diagnostics Market: Breakup by End Use (USD Billion)
8. Asia Pacific COVID-19 Diagnostics Market: Breakup by Country (USD Billion),
9. Asia Pacific COVID-19 Diagnostics Market Structure
Key Questions Answered in the Report
The Asia Pacific COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in India and China, which have performed around 234 million and 160 million tests, respectively, for COVID-19 as of March 2021.
The major drivers of the industry such as rising research and development, rising cases of COVID-19, and favourable government policies, are aiding the market growth.
The key market trend guiding the growth of the industry includes the technological advancements.
The major regions in the industry are China, India, Japan, ASEAN, and Australia, among others.
The major test types available in the industry are PCR test, antigen test, and antibody test, among others.
The major products available in the industry are RT-PCR assay kits, and immunoassay test strips, among others.
The sample types available in the market are nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others.
The significant business models are point-of-care (PoC) testing and non-point-of-care (PoC) testing.
The significant end use sectors are hospitals, diagnostic centres and clinics, and laboratories, among others.
The major players in the industry are Guangzhou Wondfo Biotech Co., Ltd., SolGent Co., Ltd., Biolidics Limited, PT Bio Farma (Persero), Beijing Jinwofu Bioengineering Technology Co.,Ltd., Mylab Discovery Solutions Pvt. Ltd., and Ellume Limited, among others.
Analyst Review
The Asia Pacific COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in India and China, which have performed around 234 million and 160 million tests, respectively, for COVID-19 as of March 2021.The market is aided by favourable government policies and rise in funding for R&D in this field.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its test types, the COVID-19 diagnostics industry can be segmented into PCR test, antigen test, and antibody test, among others. On the basis of products, the industry is divided into RT-PCR assay kits, and immunoassay test strips, among others. By sample types, the industry is categorised into nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others. On the basis of business models, the industry is segmented into point-of-care (PoC) testing and non-point-of-care (PoC) testing. Based on end use sectors, the industry is segregated into hospitals, diagnostic centres and clinics, and laboratories, among others. The major regional markets for COVID-19 diagnostics in Asia Pacific are China, India, Japan, ASEAN, and Australia, among others. The key players in the above market include Guangzhou Wondfo Biotech Co., Ltd., SolGent Co., Ltd., Biolidics Limited, PT Bio Farma (Persero), Beijing Jinwofu Bioengineering Technology Co.,Ltd., Mylab Discovery Solutions Pvt. Ltd., and Ellume Limited, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER